White Diamond @WhiteResearch

To confirm what some people are wondering, we do believe that this is the $MBOT LIBERTY System in this video, shared by the Emory physician. youtube.com/watch?v=vUNic-… But that's not necessarily a bullish sign or a change in our thesis. We're looking into it and may follow-up on what we think this means. We encourage discussion on this video if anyone has some insights.

Yes, absolutely. If we make any mistakes in our reports, we either change it in the report, or acknowledge it here on X. Like for $SEGG, we immediately tweeted our acknowledgement that the Polymarket deal was real unlike over a dozen of their fake PRs in 2025, but the bear case was still in tact. With $MBOT, i'm not aware of any mistakes in our report. What exactly are the mistakes? Thanks.

blessl @dasima499997

a month ago

@WhiteResearch 그래서 잘못된점이 있다면 고치겠다면서 언제 고칠건지? 너무 고칠게많아서 오래걸리는건가?

0 0 2 2K 0

@NeverSaid_ @seggmediacorp @Polymarket How did that work out? Oh yea, $SEGG never served Virtu the papers, the filing was the end of it.

It's too early to tell exactly how it's going to work. But apparently, $SEGG is working with Polymarket after all. They are monetizing sports.com for the first time in over 5 years. But the bear thesis is still the same. An insider told me: This new site is all polymarket technology, this is the equivalent of getting a pay per head sportsbetting site. Most likely SEGG had no real costs here. Typical for SEGG they don't disclose terms of the deal with Polymarket (rev share splits) but it doesnt matter anyway, there won't be anything to split. They need customers, so far they have one market, a few World Cup games. Polymarket gave them a deal because of the catchy Sports.com domain. The only way this business can succeed is if Sports.com had a customer base, but they have no content and no customers doing anything on Sports.com. Why would people randomly go to the sports.com predict site when they can go directly to Polymarket.

@OddDiligence Yeah, i was screwed over but managed to get out break-even. The lawsuit Honey Tree Trading v. Lottery.com is about that.

$SEGG Report Highlight: A History of SEGG Media’s Scam Press Releases We believe SEGG’s PR about a Polymarket deal is bullshit, and this is a common practice by the company. SEGG has historically published PRs with false promises of business expansion or partnerships. The expansions and partnerships never materialize, and SEGG doesn’t put out any follow-up announcements about what happened. They then move on to the next bullshit business expansion/partnership PR which doesn’t pan out to anything. The only purpose of these PRs is to give the stock a boost so the company and and insiders can sell shares. The following are 12 PRs that SEGG published in 2025 that were complete fiction. On 2/4/25, SEGG published a PR titled: Lottery.com Inc. Announces Launch of International Lottery Operations SEGG has no license and no technology to be in the lottery business. They are currently receiving zero revenue from the lottery business and management has never licensed out the lottery.com domain name. On 2/14/25, SEGG published a PR titled: Lottery.com Strengthens Its International Expansion With Technology Acquisition A follow-up 8-K wasn’t filed in regards to this all-stock purchase agreement to acquire the lottery technology. Therefore, we know the acquisition never happened. On 3/4/25, SEGG published a PR titled: Lottery.com Inc. Targets First Entry Markets in Europe and Asia Lottery.com never entered Europe or Asia. On 3/5/25, SEGG published a PR titled: Lottery.com Inc. Announces Ad-Supported Model to Diversify Sports.com Revenue Stream As we’ve shown, Sports.com has always been inactive so there has never been any ads on it. On 3/19/25, SEGG published a PR titled: Lottery.com Completes Spektrum Ltd Acquisition Deal at a $3 Share Price As we’ve shown, this technology acquisition never happened and lottery.com still has zero revenues. On 3/25/25, SEGG published a PR titled: Lottery.com Launches New Content Production and Revenue-Generating Arm: Sports.com Studios Sports.com Studios was never launched and never mentioned again. On 6/24/25, SEGG published a PR titled: Lottery.com Appoints Tim Scoffham as CEO to Lead Global Expansion of Sports.com Media and Lottery.com International Neither Sports.com nor Lottery.com were expanded. Both remain dead in the water and inactive. On 6/26/25, SEGG published a PR titled: Lottery.com Announces $10 Million Acquisition of GXR World Sports Assets to Power Global Launch of Sports.com Super App Nothing ever happened with GXR World Sports. The Sports.com “Super App” was never launched and was never mentioned again. On 6/27/25, SEGG published a PR titled: Lottery.com Closes in on Legal Action Against Coordinated ‘Short and Distort’ Campaign Nobody was ever sued, and the director who was mentioned in the PR leading the lawsuit, Christopher Gooding, immediately sold his shares right after the PR was published. On 7/9/25, SEGG published a PR titled: SEGG Media and David Lloyd Announce Groundbreaking $14M U.S. Expansion Deal Nothing ever happened from this deal, and there was no announcement that it was scrapped. On 8/1/25, SEGG published a PR titled: Lottery.com Relaunches in Mexico with Projected $5.2M Revenue as SEGG Media Puts Focus on International Gaming Operations Nothing ever happened in Mexico following this PR. It’s impossible for them to relaunch their lottery tickets because they don’t have the technology to create the tickets. On 9/4/25, SEGG published a PR titled: SEGG Media Reintroduces Lottery.com as U.S. States See iLottery Growth Ahead of Historic $1.7 Billion Jackpot Lottery.com was never reintroduced and nothing was mentioned again regarding this. On 2/10/26, SEGG published a PR titled: SEGG Media Files $179 Million Lawsuit Alleging Illegal Trading Scheme We called and verified with the Tarrant County, TX clerk that the filing of the lawsuit was the extent of it. The clerk told us that the papers were never served to the defendant. On 4/2/26, SEGG published a PR titled: SEGG Media Expands Soccerex Partnership, Positioning Sports.com at Center of Global Football Deal Ecosystem This PR “positioning sports.com at the Center of Global Football” also doesn’t make sense because sports.com isn’t operating. The Soccerex partnership hasn’t made any revenue for SEGG. The PRs above were all just published in order to get investors to want to buy the stock. None of the claims ended up happening. This makes the company a scam.

$SEGG Report Highlight: SEGG Media’s PR on 6/5/26 Is Laughable On the morning of 6/5/26, SEGG published a PR titled: SEGG Media Opens Exclusive First Access to Sports.com Predict investors.seggmediacorp.com/news-releases/… The PR states: “Following successful beta testing, first 10,000 eligible waitlist users receive phased access to real-time sports prediction markets inside Sports.com ahead of broader rollout for the 2026 FIFA World Cup” There are so many things suspicious about this PR, such as: – SEGG is claiming that there are thousands of users waiting for sports.com to become active so they can use it to make bets on Polymarket. Why don’t they just make their bets on Polymarket which is already active? There are no advantages to using sports.com as an intermediary. – We also don’t believe they have a waiting list of 10,000 people. They claim that many people entered their email on the sports.com website? We’d be surprised if there’s more than a few hundred emails. – What kind of beta testing did they do? There is nothing on the site. We believe the company so far hasn’t done anything, or beta tested anything, with sports.com or prepared at all for the World Cup, and this is just an empty PR. – The World Cup is tomorrow, there hasn’t been any scaling or preparation at all of sports.com to generate a user base.

$UMAC reached our price target of $30 today, sooner than we expected. Below is our report from 3/31/26: whitediamondresearch.com/research/we-ar…

Wow this was 2 years ago. Time flies. One thing i found interesting with $BZAI, is they said in the earnings call that they are now focusing on facial recognition software. That's what $AUID does! These frauds get involved in the same sectors.

Nader’s Alter-Ego @NaderAlterEgo

a month ago

$AUID @Shiningboy @WhiteResearch nailed this scheme. They are great shorting microcap schemes.

0 0 7 4K 0

DENSO had owned 9.2M shares of $BZAI last year, shown here: sec.gov/Archives/edgar… Today, they reported they have 0 shares. Sold it all! Shown here: sec.gov/Archives/edgar…

Thanks for the analysis. But are you really Warren Buffet? Because i don't think he invests in speculative medtech companies.

Warren Buffett @JamesLe28779865

a month ago

After reviewing the short-selling report, I feel that the scum White Diamond deliberately fabricated the narrative and lied to facilitate the short-selling attempt. @WhiteResearch @Shiningboy $MBOT

0 1 8 2K 0

Excellent, we at WDR are all for transparency in the markets. We've provided our view and facts, we'd like to see the company express their point of view in relation to our research. We are just looking to uncover the truth. We apologize if we posted inaccuracies in regards to Dr. Briggs. If there's anything incorrect with the article, we're happy to correct it so the truth is established about everything. Dr. Briggs himself stated that he's hoping the technology will improve. So if $MBOT is going to keep telling the story to investors that the LIBERTY is a great device as is and doesn't need improvement, then we think that is misleading.

David Garrity @GVAResearch

a month ago

@WhiteResearch Hear live from Dr. Charles Briggs (LIBERTY System user @ Tampa General Hospital) and Dr. Zachary L. Bercu (LIBERTY user @ Emory Healthcare) next Monday. Time for $MBOT to address @WhiteResearch note is 1500ET Mon 5/18 here: ir.microbotmedical.com/news-releases/…

0 0 5 2K 0

$MBOT - "Our first interview with a surgeon who has used the LIBERTY went from us asking how good it is to the surgeon telling us how bad it is."

White Diamond @WhiteResearch

a month ago

We Interviewed Some of the First Surgeons to use Microbot Medical’s LIBERTY Endovascular Robotic System, And It’s Clear That It Will Be A Commercial Failure – $1 Price Target Microbot Medical $MBOT has one product, the LIBERTY Endovascular Robotic System, and it has recently

0 0 1 3K 0

We Interviewed Some of the First Surgeons to use Microbot Medical’s LIBERTY Endovascular Robotic System, And It’s Clear That It Will Be A Commercial Failure – $1 Price Target Microbot Medical $MBOT has one product, the LIBERTY Endovascular Robotic System, and it has recently begun its full launch. Our research shows that it won’t sell well because it is an expensive, wasteful, unreimbursed device and doesn’t have any clinical benefits to patients. Our first interview with a surgeon who has used the LIBERTY went from us asking how good it is to the surgeon telling us how bad it is. “(The LIBERTY) is extra work, you could do the surgery yourself without the robot faster, with equal accuracy, and it’s gonna cost you an extra $3,000”, the surgeon bluntly told us. This surgeon also made the following statements: “and this is all anonymous, you know, because I don’t need the company getting pissed off at me….., but, um, you know, in its current form, I don’t know that it’s gonna impact our practice.” “And, and, you know, that’s, that’s the reality for an investor. That’s what an investor should know.” There’s no medical reimbursement for the LIBERTY. It costs hospitals an extra $3K-4K per procedure with the LIBERTY compared to doing the surgery by hand. Hospitals don’t make enough from these procedures to justify paying that much extra. The entire device is thrown away only after one use, even the bulky remote control and robotic drive unit. This is very wasteful. We also interviewed Dr. Charles Briggs from Tampa General Hospital, and he said he’s the only one there who really uses the LIBERTY out of the hospital’s 15 vascular surgeons. Briggs said he only uses the LIBERTY about once every week and a half. Because of its single-use design we can correlate infrequent use with weak sales. The LIBERTY is not ready to handle a full peripheral vascular procedure and is only compatible with the small caliber .014” guidewire, not the standard .018” guidewire. In the Needham Healthcare presentation on 4/15/26, MBOT’s Founder and CEO, Harel Gadot, stated that MBOT had $80M at the end of 2025, and will have a high $2.5M per month burn rate in 2026. That’s significantly higher than their historical monthly burn rate of about $1M, and gives them less than 3 year’s worth of cash runway. MBOT has plenty of cash for marketing the LIBERTY. However, on 4/10/26, MBOT filed to raise another $39M, which suggests there will be more dilution in the near future. Gadot was also the founder of XACT Robotics. XACT had a surgical robot similar to the LIBERTY, also used for vascular surgery, which was a commercial failure. In 2023, XACT ran out of money and shut down because it was unable to raise more investor capital. We see MBOT going down the same road. We have a $1 price target on MBOT, which we believe is generous, as the stock will likely be trading below cash value once it’s apparent that the LIBERTY is a commercial failure and the company will just be burning through its cash over the next few years. See full report here: whitediamondresearch.com/research/we-in…

We're publishing a bearish report tomorrow morning of a medtech company on which we've done extensive due diligence. Including speaking with doctors who have used the device and are disappointed with it. We did the report with one of our new analysts. We are hiring new analysts and plan on publishing reports more frequently now.